Refractory/Relapsed Acute Myeloid Leukaemia
1 clinical trials · Condition
◉ Watch Refractory/Relapsed Acute Myeloid Leukaemia
| Record | Firm | Date |
|---|---|---|
| Optimised CD33 (FL-33) CAR T Therapy for Refractory/Relapsed Acute Myeloid Leukaemia (NCT06326021) | Beijing GoBroad Hospital | 2024-04-02 |
Track Refractory/Relapsed Acute Myeloid Leukaemia automatically
Every clearance here is in the API, with alerts when new ones post.